Concourse Financial Group Securities’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5323 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6224 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6215 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6233 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6230 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6164 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6035 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5898 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5684 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5679 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5496 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5485 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5378 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5386 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5240 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5071 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4931 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4801 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4605 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4480 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4467 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4405 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4196 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4391 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4332 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4211 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3925 |
|